New personalized therapy aims to calm dementia symptoms without drugs

NCT ID NCT07356336

Recruiting now Symptom relief Sponsor: Vrije Universiteit Brussel Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a personalized, non-drug method called CoMBI to reduce troubling behaviors like agitation and anxiety in people with dementia living in nursing homes. Researchers will compare CoMBI to usual care in 60 participants to see if it improves quality of life and reduces stress for caregivers. The approach trains staff to tailor interactions based on each person's unique needs and personality.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Behavior dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Alexianen Zorggroep Tienen
RECRUITING

Tienen, Vlaams-Brabant, 3300, Belgium

Contact Phone: •••-•••-•••• Email: •••••@•••••